Antitrust: Trump 2.0’s “Deal Friendly” Merger Review

Key Takeaways

• DOJ/FTC prioritize quick clearance for non‑threatening deals.
• Early termination requests continue at high historical rates.
• Structural remedies like divestitures re‑emerge in settlements.
• 2025 saw 12 merger challenges, nine consent orders.
• Agencies will litigate only if economic harm evident.

Pulse Analysis

The merger review landscape in the United States has taken a decisive turn under the so‑called Trump 2.0 administration, which brands its antitrust posture as “deal‑friendly.” By emphasizing economic benefit over precautionary obstruction, the Federal Trade Commission and the Department of Justice have signaled a willingness to let benign transactions proceed with minimal friction. This philosophy aligns with broader pro‑business policies that aim to accelerate capital deployment and reduce regulatory lag. Consequently, corporate strategists are recalibrating deal pipelines, betting on faster approvals and lower litigation risk.

Two procedural levers illustrate the new approach. First, the revival of early terminations under the Hart‑Scott‑Rodino Act restores a practice that historically cleared roughly 80 % of requested cases, allowing parties to bypass the statutory waiting period when no antitrust concerns arise. Second, regulators have softened their stance on structural remedies, preferring divestitures over protracted court battles. Recent consent orders in high‑profile mergers—Boeing/Spirit, ACT/Giant Eagle, Synopsys/Ansys—demonstrate how agencies are crafting settlement frameworks that preserve competition while keeping deals intact.

While the environment appears more accommodating, the underlying enforcement teeth remain sharp. The 2025 record of twelve merger challenges, nine of which concluded with consent orders, shows that agencies will still intervene when a transaction threatens consumer welfare or market concentration. For investors and dealmakers, the key is rigorous pre‑merger analysis to anticipate potential remedies and to structure transactions that withstand scrutiny. As the political climate evolves, firms that balance aggressive growth ambitions with robust antitrust risk management are likely to capture the greatest value.